Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history

Main|Search|PHGKB


Last Posted: Jul 21, 2017

---

• Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history  
  KG Chaffee et al, Genetics in Medicine, July 20, 2017
• Current Status and Future Directions for Screening Patients at High Risk for Pancreatic Cancer.  
  McAllister Florencia et al. Gastroenterology & hepatology 2017 May 13(5) 268-275
• Differential analysis of mutations in the Jewish population and their implications for diseases.  
  Einhorn Yaron et al. Genetics research 2017 May 99e3
• Lost in translation: returning germline genetic results in genome-scale cancer research  
  AL Johns et al, Genome Medicine, April 2017
• Family History Helped This Survivor Catch Pancreatic Cancer Early- About 10 percent of pancreatic cancer cases are connected to family history.  
  Celgene blog post, April 25, 2017
• Genetics of Pancreatic Cancer and Its Implications on Therapy.  
  Tatarian Talar et al. The Surgical clinics of North America 2016 Dec 96(6) 1207-1221
• Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward.  
  Khan Mohammad Aslam Aslam et al. International journal of molecular sciences 2017 Apr 18(4)
• Molecular Genetics of Pancreatic Neoplasms.  
  Hosoda Waki et al. Surgical pathology clinics 2016 Dec (4) 685-703
• DNA testing of pancreatic cyst fluid: is it ready for prime time?  
  Singhi Aatur D et al. The lancet. Gastroenterology & hepatology 2017 Jan 2(1) 63-72
• A meta-analysis of the diagnostic value of detecting K-ras mutation in pancreatic juice as a molecular marker for pancreatic cancer.  
  Yang Jing et al. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 16(4) 605-14
• New era in precision medicine for pancreatic cancer  
  Science, March 23, 2017
• Surveillance of patients with hereditary gastrointestinal cancer syndromes.  
  Moreira Leticia et al. Best practice & research. Clinical gastroenterology 2016 Dec 30(6) 923-935
• The Role of BRCA2 Mutation Status as Diagnostic, Predictive, and Prognosis Biomarker for Pancreatic Cancer.  
  Martinez-Useros Javier et al. BioMed research international 2016 20161869304
• Circulating Tumor DNA May Serve as a Prognostic Marker in Pancreatic Cancer  
  J Cavallo, ASCO Post, December 20, 2016
• Circulating Tumor DNA May Serve as a Prognostic Marker in Pancreatic Cancer  
  J Cavallo, ASCO Post, December 20, 2016
• Uptake of genetic counseling, genetic testing and surveillance in hereditary malignant melanoma (CDKN2A) in Norway.  
  Levin Trine et al. Familial cancer 2016 Nov

more